Selective subtype alpha 2 adrenergic agents and methods for use thereof

Details for Australian Patent Application No. 2009206137 (hide)

Owner Allergan, Inc.

Inventors Bhat, Smita S.; Heidelbaugh, Todd M.; Fang, Wenkui K.; Li, Ling; Sinha, Santosh C.; Takeuchi, Janet A.; Chow, Ken; Nguyen, Phong X.

Agent Davies Collison Cave

Pub. Number AU-A-2009206137

PCT Pub. Number WO2009/091874

Priority 12/353,406 14.01.09 US; 61/022,142 18.01.08 US

Filing date 15 January 2009

Wipo publication date 23 July 2009

International Classifications

A61K 31/4439 (2006.01)

A61K 31/497 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/091874 Priority application(s): WO2009/091874

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009206149-Automated systems for feeding animals and collecting animal excrement

2009206128-Umbrella with repositionable grip